Oxybutynin for Post-surgical Bladder Pain and Urgency (NCT03952299)

🧪 Interventions in This Study

• Oxybutynin Transdermal Patch (DRUG)
• Oral Oxybutynin (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of California Davis Medical Center (UCDMC) — Sacramento, California

📞 Contact the Study Coordinator

Phone: (916) 734-5173

Email: avij@ucdavis.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Overactive Bladder Syndrome

• Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome — Bethesda, Maryland
• Improving Overactive Bladder Treatment Access and Adherence — Redwood City, California
• BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder — Royal Oak, Michigan

Explore by condition: All Overactive Bladder Syndrome clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.